• LAST PRICE
    31.7700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    29.7700/ 1
  • Ask / Lots
    33.8000/ 1
  • Open / Previous Close
    31.9700 / 31.7700
  • Day Range
    Low 31.4300
    High 32.7200
  • 52 Week Range
    Low 12.6350
    High 45.9900
  • Volume
    241,525
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 32.12
TimeVolumeDICE
09:32 ET220932.335
09:35 ET30032.34
09:42 ET20032.57
09:46 ET30032.72
09:48 ET80032.23
09:50 ET192432.29
09:51 ET10032.45
09:53 ET40032.25
09:55 ET40032.26
09:57 ET10032.5374
10:00 ET50032.39
10:02 ET89132.14
10:06 ET157432.31
10:08 ET70032.31
10:09 ET10032.25
10:11 ET20032.12
10:13 ET35432.17
10:15 ET68832.2
10:18 ET50032.3
10:20 ET40032.31
10:22 ET10032.42
10:24 ET20032.37
10:26 ET144332.29
10:27 ET30032.12
10:29 ET70032.24
10:31 ET57332.1
10:33 ET40032.04
10:36 ET50032
10:38 ET47532
10:40 ET40031.95
10:42 ET10031.84
10:44 ET60031.92
10:45 ET80031.98
10:49 ET70032
10:51 ET40031.98
10:56 ET70032.13
10:58 ET20032.195
11:00 ET676632.39
11:02 ET646832.325
11:05 ET80032.37
11:07 ET20032.46
11:09 ET10032.445
11:12 ET100032.25
11:18 ET41132.19
11:20 ET110032
11:25 ET155031.92
11:27 ET40032.025
11:34 ET710032.36
11:36 ET10032.355
11:39 ET50032.21
11:41 ET10032.16
11:43 ET10032.26
11:45 ET47532.08
11:50 ET10032.13
11:52 ET40032.17
11:56 ET48032.05
11:57 ET37532.02
11:59 ET40032.02
12:03 ET20031.89
12:06 ET40032.02
12:08 ET90031.98
12:17 ET20031.97
12:21 ET40031.99
12:26 ET10031.94
12:28 ET67931.93
12:30 ET130031.945
12:33 ET20031.9
12:37 ET150032.06
12:39 ET20032.055
12:42 ET20032.065
12:46 ET20032.06
12:50 ET50032.16
12:51 ET10032.28
12:53 ET20032.185
12:55 ET160032.03
12:57 ET30031.97
01:08 ET36531.87
01:09 ET30031.94
01:11 ET10031.9
01:18 ET60031.91
01:20 ET10031.95
01:22 ET20031.92
01:24 ET20031.9
01:26 ET20031.9
01:27 ET10031.905
01:31 ET80032.015
01:36 ET10031.99
01:38 ET46231.98
01:40 ET10031.91
01:44 ET10031.86
01:49 ET50031.87
01:51 ET20031.905
01:56 ET10031.86
01:58 ET20031.83
02:00 ET10031.88
02:02 ET80031.87
02:03 ET147831.6517
02:07 ET10031.75
02:09 ET40031.66
02:12 ET60031.63
02:16 ET30031.56
02:20 ET60031.43
02:23 ET40031.53
02:27 ET40031.545
02:30 ET30031.51
02:36 ET64631.475
02:38 ET20031.44
02:41 ET50031.475
02:43 ET20031.475
02:48 ET80031.53
02:50 ET10031.51
02:52 ET100031.61
02:54 ET20031.635
02:56 ET20031.66
02:57 ET10031.625
03:01 ET70031.51
03:08 ET109731.45
03:10 ET10031.485
03:12 ET70031.48
03:14 ET70031.52
03:15 ET30031.525
03:17 ET10031.54
03:19 ET70031.67
03:21 ET120031.6
03:24 ET40031.68
03:26 ET184131.7
03:28 ET50031.66
03:30 ET10031.63
03:32 ET27231.67
03:33 ET171131.66
03:35 ET20031.65
03:37 ET95031.645
03:39 ET100031.605
03:42 ET766131.595
03:44 ET30031.55
03:46 ET40031.59
03:48 ET357931.58
03:50 ET40031.505
03:51 ET100031.53
03:53 ET130031.56
03:55 ET315931.69
03:57 ET336631.79
04:00 ET534431.77
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDICE
Dice Therapeutics Inc
1.5B
-15.5x
---
United StatesIBRX
Immunitybio Inc
1.5B
-3.8x
---
United StatesREPL
Replimune Group Inc
1.5B
-10.2x
---
United StatesRYTM
Rhythm Pharmaceuticals Inc
1.5B
-7.6x
---
United StatesVRDN
Viridian Therapeutics Inc
1.5B
-8.7x
---
United StatesACLX
Arcellx Inc
1.5B
-8.1x
---
As of 2023-02-01

Company Information

DICE Therapeutics, Inc., formerly Dice Molecules Holdings LLC, is a biopharmaceutical company. The Company leverages its technology platform to build a pipeline of oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It is focused on developing oral therapeutics against targets in immunology. The Company’s platform, which it refers to as DELSCAPE, is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. Its lead therapeutic candidate, DC-806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17), which is a validated drug target implicated in a variety of immunology indications. The Company is also developing oral therapeutic candidates targeting α4ß7 integrin and αVß1/αVß6 integrin for the treatment of inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF).

Contact Information

Headquarters
279 E. Grand Avenue, Suite 300, Lobby BSOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-566-1402
Fax
302-655-5049

Executives

Independent Chairman of the Board
Richard Scheller
Chief Executive Officer, Founder, Director
J. Kevin Judice
Chief Business and Chief Financial Officer
Scott Robertson
Chief Scientific Officer
John Jacobsen
Chief Medical Officer
Timothy Lu

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5B
Revenue (TTM)
$0.00
Shares Outstanding
47.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.05
Book Value
$8.19
P/E Ratio
-15.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.